Associated Papers
Clinical Validation of Local Versus Commercial Genomic Testing in Cancer: A Comparison of Tissue and Plasma Concordance.
Faulkner LG et al.
Cancer Investigation, 2025
39989311 (PubMed )
Supplement: supplement_1.pdf
Altered cytoplasmic and nuclear ADP-ribosylation levels analyzed with an improved ADP-ribose binder are a prognostic factor in renal cell carcinoma.
Schraml P et al.
The Journal of Pathology. Clinical Research, 2023
36999983 (PubMed )
Supplement: CJP2-9-273-s001.xlsx › Tumor_39
Genetic landscape of pancreatic adenocarcinoma patients: a pilot study from Pakistan.
Ali SM et al.
Molecular Biology Reports, 2022
Mutational Profile and Potential Molecular Therapeutic Targets of Pheochromocytoma.
Ma X et al.
Frontiers in Endocrinology, 2022
35966080 (PubMed )
Supplement: Table_1.xlsx › Table_S4
Multiple mechanisms of MYCN dysregulation in Wilms tumour.
Williams RD et al.
Oncotarget, 2015
Select a paper to view details